Patent US6989891B2 successfully refreshed from Google Patents.
US6989891B2
Expired / Lapsed
US
⏱️ 0.0 years remaining
Device and method for in vitro determination of analyte concentrations within body fluids
Assignee: Optiscan Biomedical Corp
•
Filing: 2002-08-14
•
Granted: 2006-01-24
•
Expires: 2022-08-14
Abstract
Abstract A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.
Inventors
- 👤 James R. Braig
- 👤 Peter Rule
- 👤 Philip C. Hartstein
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 00:52
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/15; A61B5/157; A61B10/00; A61B10/0045; A61B5/01; A61B5/145; A61B5/14532; A61B5/1455; A61B5/150007; A61B5/150015; A61B5/150022; A61B5/150053; A61B5/150061; A61B5/150083; A61B5/150206; A61B5/150213; A61B5/150358; A61B5/150374; A61B5/150381; A61B5/150412; A61B5/150442; A61B5/150458; A61B5/150503; A61B5/150534; A61B5/15058; A61B5/150618; A61B5/150694; A61B5/150717; A61B5/150847; A61B5/15087; A61B5/151; A61B5/15134; A61B5/15136; A61B5/1514; A61B5/15186; A61B5/15188; A61B5/15192; A61B5/15194; A61B5/68; A61B5/6801; A61B5/6813; A61B5/6825; A61B5/6826; A61B5/683; A61B5/6838; G; G01; G01N; G01N21/00; G01N21/01; G01N21/03; G01N21/0332; G01N21/17; G01N21/25; G01N21/31; G01N21/35; G01N21/3577; G01N33/00; G01N33/48; G01N33/483; G01N33/487; G01N33/49; G01N33/50; G01N33/66; A61B2562/00; A61B2562/02; A61B2562/0295; A61B2562/12; A61B5/14; A61B5/1405; A61B5/1411; A61B5/15101; A61B5/15103; A61B5/15107; G01N2021/0389; G01N21/3581; G01N2201/00; G01N2201/02; G01N2201/06; G01N2201/068
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
208 words
An apparatus for determining the concentration of an analyte in a biological fluid sample drawn from a patient, the apparatus comprising: a near-patient optical detection system comprising: a source of electromagnetic radiation; a detector; an optical path extending between the source and the detector; and a filter in the optical path, the filter configured to allow passage of at least one of the following wavelengths emitted by the source: about 5.25 μm, about 6.12 μm, about 7.4 μm, about 8.0 μm, about 8.45 μm, about 9.25 μm, about 10.4 μm, about 12.2 μm; and a sample element configured for removable engagement with the optical detection system, the sample element comprising: a reagentless sample cell configured to hold the biological fluid sample, the sample cell being located in the optical path upon engagement of the sample cell with the optical detection system, the sample cell being defined by at least one window which is transmissive of infrared radiation; a sample supply passage extending from and in fluid communication with the sample cell; wherein the optical detection system further comprises a sample extractor configured to draw the biological fluid sample from the patient, and the sample supply passage is configured to conduct the biological fluid sample into the sample cell.
Claim 2
Independent Claim
208 words
An apparatus for determining the concentration of an analyte in a biological fluid sample drawn from a patient, the apparatus comprising: a near-patient optical detection system comprising: a source of electromagnetic radiation; a detector; an optical path extending between the source and the detector; and a filter in the optical path, the filter configured to allow passage of at least one of the following wavelengths emitted by the source: about 5.25 μm, about 6.12 μm, about 7.4 μm, about 8.0 μm, about 8.45 μm, about 9.25 μm, about 10.4 μm, about 12.2 μm; and a sample element configured for removable engagement with the optical detection system, the sample element comprising: a reagentless sample cell configured to hold the biological fluid sample, the sample cell being located in the optical path upon engagement of the sample cell with the optical detection system, the sample cell being defined by at least one window which is transmissive of infrared radiation; a sample supply passage extending from and in fluid communication with the sample cell; wherein the optical detection system further comprises a sample extractor configured to draw the biological fluid sample from the patient, and the sample supply passage is configured to conduct the biological fluid sample into the sample cell.
Claim 3
Dependent Claim
26 words
The apparatus of claim 1 , further comprising a membrane in fluid communication with the sample cell, the membrane configured to filter the biological fluid sample.
Claim 4
Dependent Claim
16 words
The apparatus of claim 2 , wherein the membrane is positioned within the sample supply passage.
Claim 5
Dependent Claim
31 words
The apparatus of claim 1 , wherein the sample supply passage is configured to be engaged by the sample extractor upon engagement of the sample element with the optical detection system.
Claim 6
Dependent Claim
26 words
The apparatus of claim 1 , further comprising a flow device that induces flow of biological fluid through the sample supply passage to the sample cell.
Claim 7
Dependent Claim
24 words
The apparatus of claim 5 , wherein the flow device comprises a wicking material disposed in at least portion of the sample supply passage.
Claim 8
Dependent Claim
44 words
The apparatus of claim 1 , further comprising a housing defining a chamber, the chamber being sized and configured such that at least a portion of the sample element is situated in the optical path when the sample element is situated in the chamber.
Claim 9
Dependent Claim
30 words
The apparatus of claim 7 , further comprising a visual display mounted to the housing, the visual display provides output based on at least one signal produced by the detector.
Claim 10
Dependent Claim
61 words
The apparatus of claim 1 , wherein the source of electromagnetic radiation is capable of emitting (i) an analyte beam of radiation comprising a spectral band having a center wavelength, and (ii) a calibration beam of radiation a processor in communication with the detector, and a processor is configured to compare signals corresponding to the analyte beam and the calibration beam.
Claim 11
Dependent Claim
29 words
The apparatus of claim 1 , wherein the sample element has a sample cell wall having a non-negligible absorption of the radiation emitted from the source of electromagnetic radiation.
Claim 12
Dependent Claim
24 words
The apparatus of claim 1 , wherein the sample supply passage has a length that is greater than a width of the sample cell.
References Cited (Backward Citations)
US3787124A
Cited
US3972614A
Cited
US4088448A
Cited
US4305659A
Cited
US4342516A
Cited
US4350441A
Cited
US4477190A
Cited
US4464051A
Cited
US4563090A
Cited
US4569589A
Cited
US4654197A
Cited
US4948961A
Cited
US5300779A
Cited
US4756884A
Cited
US5140161A
Cited
EP0488994A2
Cited
EP0485368A2
Cited
EP0212314A2
Cited
US5164598A
Cited
US4963498A
Cited
US5004923A
Cited
EP0483117A2
Cited
US5204525A
Cited
US4761381A
Cited
US4790640A
Cited
US4704029A
Cited
US4873993A
Cited
US5304468A
Cited
US4882492A
Cited
US5286454A
Cited
US5036198A
Cited
US5249584A
Cited
US5066859A
Cited
US5209231A
Cited
US5371020A
Cited
US5567869A
Cited
US5452716A
Cited
US5377674A
Cited
US5434412A
Cited
US6262798B1
Cited
US5515847A
Cited
US5817007A
Cited
US5857462A
Cited
US6278889B1
Cited
US5700695A
Cited
US5795543A
Cited
US6072180A
Cited
US5606164A
Cited
US6236047B1
Cited
US5605837A
Cited
US5801057A
Cited
US6048352A
Cited
US6236870B1
Cited
US6143164A
Cited
US6120676A
Cited
US6101406A
Cited
US5900632A
Cited
US6285448B1
Cited
US5798031A
Cited
US5963335A
Cited
US6049728A
Cited
US5971941A
Cited
US6119026A
Cited
US6049762A
Cited
WO1999052633A1
Cited
US6122052A
Cited
US6312888B1
Cited
US6261519B1
Cited
US6084660A
Cited
US6087182A
Cited
US6157041A
Cited
US6198949B1
Cited
WO2001060248A1
Cited
WO2001053806A1
Cited
US6591124B2
Cited
US6836332B2
Cited
US20030086073A1
Cited
US20030090649A1
Cited
US20030086075A1
Cited
US20030178569A1
Cited
US20040019431A1
Cited
US20040133084A1
Cited
US20040132167A1
Cited
US20040132168A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2009-01-23 | 2009-07-25 | 2010-01-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2013-01-23 | 2013-07-25 | 2014-01-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2017-01-23 | 2017-07-25 | 2018-01-24 | $7700.00 | Window Closed / Lapsed |